ZFIN ID: ZDB-TALEN-170123-1
TALEN Name: TALEN1-nfe2
Target: nfe2 (1)
Source:
Target Sequence 1:
5' - TCACCCACCTCTTATGAG - 3'
   
Select Sequence Analysis Tool

Target Sequence 2:
5' - TGACCACGTGTAGTCATG - 3'
   
Select Sequence Analysis Tool

  (Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.)
TARGET LOCATION
No data available
CONSTRUCTS WITH SEQUENCES FROM TALEN1-nfe2 No data available
GENOMIC FEATURES CREATED WITH TALEN1-nfe2
Genomic Feature Affected Genomic Regions    
mi4002 nfe2    
GENE EXPRESSION
Gene expression in Wild Types + TALEN1-nfe2 No data available
PHENOTYPE
Phenotype resulting from TALEN1-nfe2
No data available

Phenotype of all Fish created by or utilizing TALEN1-nfe2
Phenotype Fish Conditions Figures
whole organism anterior-posterior axis increased curvature, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. S4 from Williams et al., 2016
swim bladder uninflated, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. S1 from Williams et al., 2016
whole organism cfap70 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
whole organism cyp4v7 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
whole organism fhad1 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism spi2 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
whole organism dhx40 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism linc-nlrp12 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
blood circulation disrupted, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. S4 from Williams et al., 2016
whole organism anterior-posterior axis increased curvature, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. S1Fig. S4 from Williams et al., 2016
heart contraction increased rate, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. S1 from Williams et al., 2016
whole organism spi2 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism slc16a6a expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism dnajb9b expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
pericardium edematous, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. S1 from Williams et al., 2016
swim bladder inflation delayed, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. S1 from Williams et al., 2016
whole organism gpr19 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
whole organism gpr19 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism gpr19 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
whole organism dnajb9b expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
whole organism dhx40 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
blood circulation disrupted, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. S1Fig. S4 from Williams et al., 2016
swim bladder inflation delayed, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. S3 from Williams et al., 2016
whole organism slc35f4 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
whole organism cfap70 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
otolith mislocalised, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. S1 from Williams et al., 2016
whole organism slc16a6a expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
whole organism slc35f4 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
whole organism dnajb9b expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
heart contraction decreased rate, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. S1 from Williams et al., 2016
whole organism fhad1 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
nucleate erythrocyte low saturation, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 2Fig. 3Fig. S4 from Williams et al., 2016
whole organism linc-nlrp12 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism slc16a6a expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
whole organism cyp4v7 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism cfap70 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism slc35f4 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 6 from Williams et al., 2016
whole organism cyp4v7 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
nucleate erythrocyte low saturation, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: tert-butyl hydroperoxide Fig. 2Fig. 3Fig. S1Fig. S4 from Williams et al., 2016
whole organism dhx40 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 6 from Williams et al., 2016
whole organism fhad1 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
nucleate erythrocyte low saturation, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. 2Fig. 3Fig. S1Fig. S3Fig. S4 from Williams et al., 2016
whole organism linc-nlrp12 expression decreased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
whole organism spi2 expression increased amount, abnormal nfe2mi4002/mi4002(AB/TL) chemical treatment by environment: diquat Fig. 6 from Williams et al., 2016
otolith mislocalised, abnormal nfe2mi4002/mi4002(AB/TL) standard conditions Fig. S3 from Williams et al., 2016
OTHER TALEN1-nfe2 TALEN PAGESNo links to external sites
CITATIONS (2)